
Stock·NASDAQ·Consumer Defensive
The Campbell's Company (CPB)
- Market cap
- $7.11B
- P/E
- 18.15
- Dividend yield
- 4.21%
- Street target
- $19.00median of 20 analysts
- 52-week range
- $18.60 $31.66
What moved The Campbell's Company (CPB)
Updated . Market figures as of November 20, 2026.
Was it the market or the company?
On November 20, 2026, CPB rose 1.84%. The same day the S&P 500 (SPY) fell 3.64% and the Nasdaq 100 (QQQ) fell 5.67%.
The move was in line with the market. CPB's one-year beta to SPY is -0.35, so SPY's -3.64% would on average have meant +1.26% for CPB, close to what it did (0.6 percentage points more).
So most of the day's move came with the market; the dated news below is the company-specific backdrop, not the main driver of that session.
Over the last 20 sessions CPB is up 14.71% against -9.23% for SPY, 23.9 percentage points ahead of it.
The wider market on November 20, 2026: CNBC reported that the sell-off's breaking point came with Anthropic's initial public offering and heavier selling in Nvidia, which it named as the first of five forces behind the drop. (CNBC, November 20, 2026)
| That day | 5 sessions | 20 sessions | |
|---|---|---|---|
| CPB | +1.84% | +4.44% | +14.71% |
| S&P 500 (SPY) | -3.64% | -8.56% | -9.23% |
| Nasdaq 100 (QQQ) | -5.67% | -10.51% | -13.62% |
Calculated by CleaRank from daily closes. Beta is measured on the last year of daily returns against SPY. A description of what happened, not a forecast.
In the news
The company said it will report first-quarter fiscal 2027 results on December 9, 2026, covering the period ended November 2, 2026.
· Company or regulator statement · Source: The Campbell's Company
CPB stock today, November 22, 2026: price, news and analyst targets
As of November 20, 2026, The Campbell's Company (CPB) trades at $23.78. Wall Street's median 12-month price target is $19.00 across 20 analysts, 20.1% below the price. CleaRank rates it Buy with a score of 62/100.
The Campbell's Company (CPB) has pulled back from its 52-week high of $31.66 and now trades at $23.78, up 21.57% over the past month and 4.44% over the past week. The stock is above its 50-day, 200-day and 20-day averages, and its 14-day RSI of 62.8 sits in the bullish zone. The rally has not closed the gap with Wall Street, where the median 12-month target of $19.00 sits 20.1% below the price.
What has moved the stock recently
CPB rose 3.17% on November 13, 2026, closing at $22.77, and it closed above its 200-day average that day at $22.77 against $22.25. On November 18, 2026, the stock rose 3.39% to close at $24.38, and on November 19, 2026, it fell 4.23% to close at $23.34. The stock has been moving more than its usual daily range in these sessions, but its 30-day typical daily move is 2.69%, so these swings sit within a normal pattern for the stock.
Earnings have been mixed
Of the seven most recent reports, five beat the EPS estimate and one missed it. The September 3, 2026 report matched the estimate at $0.39, and the stock fell 3.39% in the first session after it. The March 11, 2026 report missed at $0.51 against $0.57, followed by a 5.62% decline. The June 8, 2026 report beat at $0.50 against $0.48, followed by a 2.98% gain. Two of the five beats were followed by a lower share price in the first session, so a beat has not reliably lifted the stock. Revenue shrank 4.40% in the latest quarter year on year, slower than the sector median growth of 5.3%.
Valuation and the business
The trailing P/E of 18.15 is a discount to the sector median of 24.2, and the price-to-sales ratio of 0.73 compares with a sector median of 2.2. The trailing dividend yield is 4.21%, based on an annual dividend of $1.00. Return on equity of 10.05% is below the sector median of 19.7%, and debt-to-equity of 1.79 is a point of caution for a company whose revenue is shrinking. The business has a 12.39% operating margin and a 6.12% net margin, so it is profitable but not growing its top line.
Analyst stance
Of 20 analysts with a current rating, one rates the stock buy or strong buy, 13 rate it hold and six rate it sell or strong sell. Three months ago the split was one buy among 20 ratings, so the mix has not changed in that period. On September 14, 2026, Evercore ISI Group kept its In-Line rating, and on September 4, 2026, UBS kept its Sell rating and Barclays kept its Underweight rating. The median target of $19.00 is 20.1% below the price.
CleaRank score 62/100 (Buy). 10 of 19 checks pass: trend 2 of 4, momentum 3 of 3, valuation and quality 5 of 5, analysts 0 of 3, track record 0 of 4.
About The Campbell's Company
-based consumer staples business focused on food and beverage products. The company serves retail, foodservice, and commercial customers through two main segments: Meals & Beverages and Snacks. Its portfolio includes soups, broths, sauces, beverages, cookies, crackers, pretzels, chips, and other shelf-stable packaged foods sold under well-known brands such as Campbell’s, Pepperidge Farm, Goldfish, Prego, Pace, Swanson, V8, Snyder’s of Hanover, and Cape Cod.
CPB stock news
Earnings date set
The report is the next test of the revenue decline and the earnings estimates for the year.
Sell-side ratings held
·UBS
UBS kept its Sell rating and Barclays kept its Underweight rating on September 4, 2026, after the September 3 report. Those ratings sit alongside six sell-rated analysts and keep pressure on the stock's valuation case.
Evercore keeps In-Line rating
·Evercore ISI Group
Evercore ISI Group kept its In-Line rating on September 14, 2026. The rating is neutral and does not change the consensus of Hold.
CPB price target 2026
The base case is that CPB holds above its moving averages while investors wait for the December 9, 2026 first-quarter report, with the stock trading in a range set by its recent momentum and its low beta of 0.05. Revenue shrank 4.40% in the latest quarter year on year, and analysts expect fiscal 2027 revenue to shrink 2.5% and EPS to fall 21.9% to $1.70, before growth of 8.3% to $1.84 in fiscal 2028. Those forecasts keep the Wall Street stance at Hold, with one buy rating against six sell ratings. A better outcome would require revenue growth to return and EPS to meet or beat expectations, which would give the rally firmer support. A worse outcome would be a revenue miss or a guidance cut, which could take the price back toward the averages near $22 and the 50-day average at $20.95. Analysts' targets range from $16.00 to $41.50, with a median of $19.00, so the gap between the price and most targets is the central tension for the stock.
Analyst targets and ratings
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 14, 2026 | Evercore ISI Group | Maintains | In-Line |
| Sep 8, 2026 | DA Davidson | Maintains | Neutral |
| Sep 4, 2026 | RBC Capital | Maintains | Sector Perform |
| Sep 4, 2026 | UBS | Maintains | Sell |
| Sep 4, 2026 | Barclays | Maintains | Underweight |
| Sep 4, 2026 | Jefferies | Maintains | Hold |
CPB support and resistance levels
Nearest support is the 20-day exponential moving average at $22.55, which the price sits just above. Below it, the 200-day simple moving average at $22.14 is the next level a fall would meet, and it is the level the stock has been trading around over the past few weeks. The 50-day simple moving average at $20.95 is the third support, and the 52-week low of $18.60 is the deepest floor. On the upside, the 52-week high of $31.66 is the only resistance level above the price, so a rise would first meet that mark.
| Level | What it is | Price | From the price |
|---|---|---|---|
| Resistance 1 | 52-week high | $31.66 | +33.1% |
| Price | November 20, 2026 | $23.78 | |
| Support 1 | 20-day exponential average | $22.55 | -5.2% |
| Support 2 | 200-day moving average | $22.14 | -6.9% |
| Support 3 | 50-day moving average | $20.95 | -11.9% |
| Support 4 | 52-week low | $18.60 | -21.8% |
Technical indicators
CPB technical analysis in depth
Volatility, momentum, trend strength and the price levels that matter for CPB, calculated by CleaRank from daily bars to November 20, 2026.
Volatility
On the 20-day Bollinger Bands (2 standard deviations) the bands run from $20.26 to $24.68 around a middle of $22.47, and CPB's close of $23.78 sits inside the bands, away from both edges.
Band width is 19.7% of the price, in the middle of its range over the last 120 sessions.
The 14-day average true range is $0.8688, or 3.7% of the price: a typical day's swing from high to low. A stop placed 1.5 ATR away would sit about 5.5% from the close.
Momentum and volume
The 14-day stochastic reads 78 (signal line 82): the close is in the middle of its two-week range.
The MACD line (12, 26) is 0.807 against a signal line (9) of 0.711, so the histogram is positive: momentum is improving relative to its recent average. The MACD line crossed above its signal line 29 sessions ago.
Volume in the latest session was 1.5 times its 20-day average, heavy enough to give the move more weight.
Trend strength
The 14-day ADX is 33: a trending market, with buyers in control (+DI 33, -DI 16).
On the weekly chart the 10-week average ($21.06) is below the 40-week average ($21.95), a falling longer-term trend, and the weekly RSI is 58.
Key levels
The nearest resistance from the price history is $25.76 (+8.3%): the price turned here 2 times, most recently on January 20, 2026.
The nearest support is $23.72 (-0.3%): the price turned here 7 times, most recently on November 5, 2026.
The largest swing of the last 120 sessions ran up from $18.60 (October 7, 2026) to $24.39 (November 18, 2026); the nearest Fibonacci retracement to the price is the 23.6% level at $23.02.
Classic pivot points for the next session, from November 20, 2026: pivot $23.93, resistance $24.22 and $24.66, support $23.49 and $23.20.
| Level | Price | From the price | What it is |
|---|---|---|---|
| Resistance (swing high) | $30.32 | +27.5% | the price turned here 2 times, most recently on February 13, 2026 |
| Resistance (swing high) | $27.75 | +16.7% | the price turned here 2 times, most recently on December 23, 2025 |
| Resistance (swing high) | $25.76 | +8.3% | the price turned here 2 times, most recently on January 20, 2026 |
| Upper Bollinger Band | $24.68 | +3.8% | 20-day average + 2 standard deviations |
| Pivot R2 (classic) | $24.66 | +3.7% | next-session level |
| Pivot R1 (classic) | $24.22 | +1.9% | next-session level |
| Pivot R1 (Fibonacci) | $24.21 | +1.8% | 38.2% of the last range above the pivot |
| Pivot point | $23.93 | +0.6% | average of the last high, low and close |
| Price | $23.78 | close, November 20, 2026 | |
| Support (swing low) | $23.72 | -0.3% | the price turned here 7 times, most recently on November 5, 2026 |
| Pivot S1 (Fibonacci) | $23.65 | -0.5% | 38.2% of the last range below the pivot |
| Pivot S1 (classic) | $23.49 | -1.2% | next-session level |
| Pivot S2 (classic) | $23.20 | -2.4% | next-session level |
| Fibonacci 23.6% | $23.02 | -3.2% | retracement of the rise from $18.60 to $24.39 |
| Support (swing low) | $22.29 | -6.3% | the price turned here 2 times, most recently on August 11, 2026 |
| Fibonacci 38.2% | $22.18 | -6.7% | retracement of the rise from $18.60 to $24.39 |
| Fibonacci 50.0% | $21.50 | -9.6% | retracement of the rise from $18.60 to $24.39 |
| Support (swing low) | $21.36 | -10.2% | the price turned here 7 times, most recently on November 11, 2026 |
| Fibonacci 61.8% | $20.81 | -12.5% | retracement of the rise from $18.60 to $24.39 |
| Lower Bollinger Band | $20.26 | -14.8% | 20-day average - 2 standard deviations |
| Fibonacci 78.6% | $19.84 | -16.6% | retracement of the rise from $18.60 to $24.39 |
Swing levels are highs and lows the price turned at (the extreme of the five sessions either side), merged when they sit within 1.2 average true ranges of each other. Bollinger Bands (20, 2), ATR (14, Wilder), stochastic (14, 3), MACD (12, 26, 9), ADX (14, Wilder). Readings describe the chart; they are not a forecast.
CPB stock price and trading
CPB share price
CPB fundamentals and valuation
Key statistics
CPB against the Consumer Defensive sector
Price to earnings vs sector: CPB trades at a notable discount to sector peers (-25% against the sector median P/E). Investors are paying less for each dollar of earnings than for the typical stock in the sector.
Return vs SPY: Since Jun 11, 2025, CPB has lost 28.8% against a gain of 14.7% for SPY.
Performance against SPY
Revenue and earnings
Revenue growth: Revenue grew 6.4% in FY2025 to $10.3B, from $9.6B a year earlier.
Profit margin: The net margin was 5.9% in FY2025, unchanged from the year before.
Profitable: CPB earned $602M in FY2025.
Earnings reality check
Earnings record: CPB beat the analyst estimate in 5 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 2 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 3, 2026 | $0.39 | $0.39 | +0.00% | -3.39% | -5.11% |
| Jun 8, 2026 | $0.48 | $0.50 | +4.17% | +2.98% | +3.82% |
| Mar 11, 2026 | $0.57 | $0.51 | -10.53% | -5.62% | -8.11% |
| Dec 9, 2025 | $0.73 | $0.77 | +5.48% | -1.02% | +0.74% |
| Jun 2, 2025 | $0.66 | $0.73 | +10.61% | +0.03% | +0.06% |
| Mar 5, 2025 | $0.72 | $0.74 | +2.78% | +1.56% | -1.53% |
| Dec 3, 2024 | $0.87 | $0.89 | +2.30% | -6.24% | -4.37% |
CPB price history and drawdowns
Risk profile
Worst falls and recoveries
Growth of $10,000
Against the market: CPB trailed the S&P 500 over this period: $5,909.73 against $36,764.
A $10,000 investment in CPB in December 2016 would be worth about $5,910 today with dividends reinvested, compared with about $36,764 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
CPB stock price prediction 2030
CPB Stock Price Prediction 2030: Simulated Scenarios
CleaRank's simulation projects a price near $22.27 for CPB by 2030 in the base case, from $23.78 today (0.9x over 4 years). The 10th-percentile path ends near $11.27. These are outcomes of a Monte Carlo simulation run on CPB's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $16.64 | $23.39 | $32.88 | |
| 2028 | $14.22 | $23.01 | $37.24 | |
| 2029 | $12.55 | $22.64 | $40.81 | |
| 2030 | $11.27 | $22.27 | $43.98 |
CPB insider trading
CPB insider trading
Month by month
Net insider selling: Insiders bought $6K on the open market and sold $397K.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Mohit Anand
Officer
|
Grant | 25.2K | - |
| Oct 1, 2026 | Mick J Beekhuizen
Chief Executive Officer
|
Grant | 152.9K | - |
| Oct 1, 2026 | Charles A. Brawley III
Officer
|
Grant | 40.4K | - |
| Oct 1, 2026 | Risa Cretella
Officer
|
Grant | 27.1K | - |
| Oct 1, 2026 | Todd E Cunfer
Chief Financial Officer
|
Grant | 31.2K | - |
| Oct 1, 2026 | Cassandra Green
Officer
|
Grant | 18.8K | - |
| Oct 1, 2026 | May Diane Johnson
Officer
|
Grant | 42.1K | - |
| Oct 1, 2026 | Janda K Lukin
Officer
|
Grant | 20.3K | - |
| Oct 1, 2026 | Melissa Nippert
Officer
|
Grant | 19.7K | - |
| Oct 1, 2026 | Melissa Nippert
Officer
|
Grant | 10.5K | - |
CPB stock forecast: questions people ask
CPB Forecast: Frequently Asked Questions
What is the CPB stock forecast?
What is the CPB price target?
Is CPB a buy or sell today?
Why did the stock rise in November?
How has CPB performed over the past year?
How does CPB's valuation compare with its sector?
How these figures are computed, and where the data comes from: CleaRank methodology.